THERAMAP
TheraGenetics Limited
Application Filed: 2008-02-05
Trademark Application Details
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77388974 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Lisa A. Osman |
| Attorney Name | Lisa A. Osman |
| Attorney Docket Number | 72072US |
| Law Office Assigned | M50 |
| Employee Name | PINO, BRIAN J |
Timeline
| 2008-02-05 | Application Filed |
| 2009-12-24 | Abandon |
| 2010-01-19 | Location: TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED |
| 2010-01-19 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  TheraGenetics Limited |
| Address | Inst. of Psychiatry Kings College London De Crespigny Park, P.O. 51 Denmark Hill London GB SE58AF |
| Legal Entity Type | Company |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Advisory services relating to diagnostic preparations and products, namely, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for psychiatric disorders, consulting and advisory services relating to the development, testing and efficacy, of pharmaceutical preparations and products for the treatment of diseases and disorders of the central nervous system, consulting and advisory services relating to the development, testing and efficacy, of pharmaceutical preparations and products for the treatment of Psychiatric diseases and disorders, and consulting and advisory services relating to the provision of goods containing reagents for use in the collection and testing of DNA, RNA and bodily tissues; advisory services relating to diagnostic apparatus and diagnostic instruments, namely, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for psychiatric disorders, relating to apparatus and instruments used in the prediction of the response of individuals to pharmaceutical products and treatment for diseases and disorders of the central nervous system, relating to apparatus and instruments used in the prediction of the response of individuals to pharmaceutical products and treatment for psychiatric diseases and disorders, consulting and advisory services relating to the development, testing and efficacy, of apparatus and diagnostic instruments for the treatment of diseases and disorders of the central nervous system, consulting and advisory services relating to the development, testing and efficacy, of pharmaceutical preparations and products for the treatment of psychiatric diseases and disorders, in connection with assays or assay kits for use in the collection and testing of DNA, RNA and bodily tissues, and in connection with assay kits (which may contain reagents) for use in the collection of DNA, RNA and bodily tissues; design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments, for disorders of the central nervous system; design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments, for psychiatric disorders; design and control of pharmacogenetic diagnostic tests for disorders and diseases of the central nervous system; design and control of pharmacogenetic diagnostic tests for psychiatric diseases and disorders; design and control of pharmacogenetic tests, including the devising, compiling and testing of algorithms and mathematical systems for predicting response to a pharmaceutical product based on individual genetic profile; scientific research related to pharmacogenetics; research and advisory services relating to pharmaceuticals |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2008-02-08 | 1 NWAP I:Incoming Correspondence |
| NOTICE OF PSEUDO MARK MAILED | 2008-02-09 | 2 MPMK O:Outgoing Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2008-02-15 | 3 PARI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2008-03-13 | 4 ALIE A:Allowance for Publication |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2008-03-19 | 5 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2008-04-29 | 6 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 2008-04-30 | 7 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2008-05-05 | 8 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2008-05-05 | 9 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2008-05-05 | 10 GNRN O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2008-06-06 | 11 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2008-11-05 | 12 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2008-11-07 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2008-11-07 | 14 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2008-11-24 | 15 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2008-11-24 | 16 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2008-11-24 | 17 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2008-12-09 | 18 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2008-12-11 | 19 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2008-12-11 | 20 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2008-12-23 | 21 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2008-12-23 | 22 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2008-12-23 | 23 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2008-12-23 | 24 XAEC I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2008-12-23 | 25 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2008-12-23 | 26 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2008-12-23 | 27 GNS3 O:Outgoing Correspondence |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2009-06-23 | 28 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2009-06-23 | 29 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2009-06-23 | 30 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2009-06-23 | 31 GNS2 O:Outgoing Correspondence |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2010-01-19 | 32 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2010-01-19 | 33 MAB2 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 THERAMAP 87455849 5482458 Live/Registered |
IHC HEALTH SERVICES, INC. 2017-05-18 |
 THERAMAP 77388974 not registered Dead/Abandoned |
TheraGenetics Limited 2008-02-05 |
 THERAMAP 77153197 not registered Dead/Abandoned |
ICAD, INC. 2007-04-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 